Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$1.31 - $2.69 $551,533 - $1.13 Million
-421,018 Reduced 66.44%
212,620 $410,000
Q1 2022

May 18, 2022

BUY
$1.95 - $3.89 $107,753 - $214,953
55,258 Added 9.55%
633,638 $1.41 Million
Q4 2021

Feb 14, 2022

SELL
$3.81 - $6.16 $332,864 - $538,174
-87,366 Reduced 13.12%
578,380 $2.28 Million
Q3 2021

Nov 15, 2021

SELL
$3.38 - $5.35 $855,210 - $1.35 Million
-253,021 Reduced 27.54%
665,746 $3.21 Million
Q1 2021

May 17, 2021

BUY
$3.45 - $9.09 $3.17 Million - $8.35 Million
918,767 New
918,767 $5.4 Million

Others Institutions Holding LXRX

About LEXICON PHARMACEUTICALS, INC.


  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $134M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.